Navigation Links
SNM receives grant from AHRQ for comparative effectiveness research
Date:4/13/2010

RESTON, Va.SNM has been awarded a $48,000 grant from the Agency for Healthcare Research and Quality (AHRQ) to hold a conference to develop research on the comparative effectiveness of positron emission tomography (PET) and other molecular imaging techniques. The primary emphasis will be on the diagnosis and management of cancer patients, but both cardiology and neurology questions will also be addressed.

"Comparative effectiveness research is essential to the future of medical imaging and improved patient care," said Michael M. Graham, Ph.D., M.D., president of SNM and principal investigator. "This grant will allow us to effectively define how to carry out the research needed to educate the health care community about the benefits of PET and PET/CT for the management and care of cancer patients."

Three years ago, SNM's PET Center of Excellence created a PET Utilization Task Force to address specific challenges within the field. The Research Working Group, a subset of the PET Utilization Task Force (directed by Graham), met last August in Denver, Colo., to begin development of a cost effectiveness research workshop. This workshop is a first step in the development of substantial cost and clinical effectiveness research focused on PET/CT and molecular imaging in the fields of oncology, cardiology and neurology. A key component of this workshop is the collaboration of experts in molecular imaging together with leaders in health services research with the goal of defining the optimal methodology and producing a plan for one or more molecular imaging effectiveness research projects.

With the grant from AHRQ, SNM will host the workshop, "Comparative Effectiveness in Molecular Imaging," July 21-22, in the Washington, D.C. area. The two-day workshop will review the current information on molecular imaging, current healthcare costs and how clinical and cost effectiveness research can be a valuable method of addressing all of these issues for managing the treatment and care of cancer patients in today's health care environment.

In addition to SNM's experts in PET/CT, the symposium will include experts from other areas of molecular imaging likely to be important in the future, and also investigators from the National Oncology PET Registry, who have experience in registries applied to PET utilization. Approximately 100-120 attendees will include decision makers from funding agencies, the academic imaging community, the surgical/clinical oncology, cardiology and neurology communities, and from the health services research community, industry and patient advocacy groups. The meeting will include focused discussion groups charged with the goal of formulating research plans. The result of the meeting will provide guidance for how to optimally approach future molecular imaging comparative effectiveness research.

"While many studies on molecular imaging have demonstrated clinical potential, there is a need for strong comparative effectiveness evidence," Graham said. "This is why it is so important that we formulate a comparative effectiveness research plan to evaluate molecular imaging for the management of cancer."

Establishing clinical and cost effectiveness research for molecular imaging has been a top priority for Graham, and one of his major goals since taking office as SNM president in June 2009.


'/>"/>

Contact: Amy Shaw
ashaw@snm.org
703-652-6773
Society of Nuclear Medicine
Source:Eurekalert

Related medicine news :

1. University of Arizona Superfund Research Program receives $14 million
2. Jefferson researcher receives 2010 Pancreatic Cancer Action Network-AACR Career Development Award
3. Proton's T-4 Automatic Degausser Receives “Best of FOSE 2010” Award
4. M. D. Anderson receives 4.5 million grant, largest ever for study of yoga and cancer
5. UTHealth receives $15 million for health information technology research
6. European hematologist receives award to conduct research in US
7. Advans Receives 2009 Best of Business Award
8. More Than Gourmet Receives AVA Vegan Certification Award
9. EVMS receives more than $1 million in federal funds to develop new ways to reverse type 1 diabetes
10. US Wellness, Inc. Receives National Recognition for Laboratory Excellence
11. American Public Health Champion Receives 2010 Stockholm Water Prize
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... company is unveiling its revolutionary new 2.0 version at the International Roofing Expo ... “put the power of the world's most advanced weather technology in the hands ...
(Date:2/10/2016)... Garland, TX (PRWEB) , ... February 10, 2016 ... ... the commencement of a master charity program created to assist the local community. ... closely with community leaders and nonprofit organizations in the area. Their goal is ...
(Date:2/10/2016)... ... , ... Ongoing news of the ravages of traumatic brain injury (TBI) among ... that takes a closer look at cases of TBI being managed by their members. ... among the aging population, and identifies the challenges associated with their care. , During ...
(Date:2/10/2016)... ... 2016 , ... Armune BioScience signed a definitive agreement with ... centers across the country. Launched in April of 2015, Apifiny is the only cancer ... Apifiny order volume exceeded 3,000 tests in 2015. Primary care physicians and urologists have ...
(Date:2/10/2016)... ... February 10, 2016 , ... The ... been awarded the prestigious Distinguished Emerald Club of the World award, as determined ... magazine, one of the most respected trade publications serving private clubs. , “We’d ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... Jersey and OR AKIVA, Israel ... Regentis Biomaterials Ltd., a leader in the ... Series D investment round on February 5, 2016. The ... Group ("Haisco"), a leading Chinese pharmaceutical manufacturer, and ... SCP Vitalife Partners, Generali Financial Holdings and both the ...
(Date:2/10/2016)... Feb. 10, 2016  Silicon Biosystems Menarini Inc., ... that help uncover the biological complexities of disease ... a developer of innovative technologies for genomics research, ... aimed at enabling translational researchers to obtain high-quality ... hundred tumor and normal cells in an optimized ...
(Date:2/10/2016)... 2016 On Tuesday, February 9th, the ... with its Arthritis Advisory Committee to discuss ... & Johnson,s Remicade and most likely the ... U.S. The Biologics Prescribers Collaborative (BPC) along ... for Patient Access, American Association of Clinical ...
Breaking Medicine Technology: